Skip to main content
Home

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoNTD

  • NTDs [14]
    • Buruli ulcer
    • Chagas disease
    • Dracunculiasis
    • Human African trypanosomiasis
    • Leishmaniasis
    • Leprosy
    • Lymphatic filariasis
    • Mycetoma
    • Onchocerciasis
    • Schistosomiasis
    • Snakebite envenoming
    • Soil-transmitted helminthiasis
    • Trachoma
    • Yaws
  • Cross-cutting issues [13]
    • Data management & analysis [3]
      • Data collection and reporting
      • Mapping
      • Indicators
    • Integrated wound management
    • Capacity strengthening
    • Management of disease complications [2]
      • Medical management
      • Surgical management
    • Prevention of disability [3]
      • Eye care
      • Self-care
      • Disability measurement
    • Physical rehabilitation [3]
      • Physical therapy
      • Orthopaedic footwear
      • Protheses, walking devices and wheelchairs
    • Stigma and mental wellbeing [1]
      • Mental wellbeing project mapping
    • Inclusion [2]
      • Community-based rehabilitation
      • Gender
    • WASH and NTDs
    • Health systems factors
    • Skin-NTDs
    • Preventive Chemotherapy
    • Health education
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • Perception Study Toolkit (PST)
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • NTD Toolbox
    • CBM's Community Mental Health Good Practice Guides
  • Online courses

Top menu infoNTD

  • About InfoNTD
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Event
03/10/2024
 till  03/10/2024

Neglected tropical diseases in Francophone countries

Online
Publication

Correlation of Dermatoscopic Findings in Leprosy with Clinical Spectrum and Histopathology: A Prospective Observational Study

Chenganasseri SH, Kapilavayi S, Divya B, et al. Indian Journal of Leprosy. 2024;
Download PDF
Publication

Social Work with Populations Vulnerable to Neglected Tropical Diseases

Jabir M, Choolayil A. Springer Nature. 2024;
Event
21/10/2024
 till  25/10/2024

75th Session of the WHO Regional Committee for the Western Pacific

Manila, phillipines
Publication

Managing a Case of Steroid Dependant Erythema Necroticans in a Severely Immune-compromised Patient: Case report

Mishra S, Madhual S, Panda M. Indian Journal of Leprosy. 2024;
Download PDF
Publication

Concomitância da hanseníase virchowiana e carcinoma de células escamosas: relato de caso

Hatanaka H, Dornelas BDC, Girardi PDS, et al. Hansenologia Internationalis: leprosy and other infectious diseases. 2024;
Download PDF
Publication

New multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy preliminary report

Chaudhury S, Hazra S, Podder G, et al. Indian Journal of Dermatology. 1987;
Download PDF
Publication

Leprosy in the Modern Age: clinical diagnosis and challenges in the 21st Century

Jaiswal B, Rajpurohit P, Munot Y, et al. Medic Scientific. International journal of therapeutic innovation. 2024; 2 (4) : 192-202.
Download PDF
News
19/09/2024

Jordan becomes first country to receive WHO verification for eliminating leprosy

WHO .
News
18/09/2024

WHO's goodwill ambassador Yohei Sasakawa urges for collaboration to eliminate leprosy

Himalayan News Service .

Pagination

  • Previous page ‹ ‹ Previous
  • …
  • Page 91
  • Page 92
  • Page 93
  • Page 94
  • Current page 95
  • Page 96
  • Page 97
  • Page 98
  • Page 99
  • …
  • Next page Next › ›
  • Last page Last » »
Subscribe to

Quick Links

  • Toolbox
  • Publications
  • Organizations
  • NTDs

Support

  • Contact
  • FAQ
  • Privacy statement

Contact us infoNTD

info@InfoNTD.org

(+31) 20 595 0526

     

Stay up to date with the latest developments in NTDs. We share a monthly overview via email showing a selection of the latest NTD publications and tools. 

Subscribe

Related websites:

© 2025 InfoNTD